Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
Clinical trial NCT00418548 · COMPLETED
Trial details
- NCT number
- NCT00418548
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.